Novavax seals COVID-19 vaccine deal with Australia

Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Novavax partners with Takeda to deliver COVID-19 vaccine in Japan

10 August 2020 US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.

Americas

Moderna unsure of COVID-19 vaccine patent exclusivity

12 August 2020 US biotech company Moderna has said it’s possible that it may not be the first company to make the inventions claimed in its pending patent applications, which include the breakthroughs for its experimental COVID-19 vaccine.

More on this story

Big Pharma

Novavax partners with Takeda to deliver COVID-19 vaccine in Japan

10 August 2020 US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.

Americas

Moderna unsure of COVID-19 vaccine patent exclusivity

More on this story

Big Pharma

Novavax partners with Takeda to deliver COVID-19 vaccine in Japan

10 August 2020 US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.

Americas

Moderna unsure of COVID-19 vaccine patent exclusivity